Age, menopause, clinical stage, tumor grade, tumor type, tumor size, lymph node metastasis and CTHRC1 level were correlated with the overall survival (p = 0.039, 0.011, < 0.001, 0.001, 0.025, 0.014, < 0.001 and 0.004, respectively; Table 2). This evidence concerns the gene CTHRC1 and neoplasm.